The patient received chemotherapy, followed by programmed cell death 1 (PD-1) inhibition with camrelizumab, and died 10 months after surgery.<h4>Conclusion</h4>Thyroid NC is an extremely rare and fatal malignant tumor. This evidence concerns the gene PDCD1 and cancer.